2026 Annual Meeting - Agenda

Effective STEMI care depends on seamless coordination between physicians and cardiovascular technologists, from first medical contact through reperfusion. This session examines how well-designed STEMI systems of care reduce treatment delays and improve outcomes, highlighting the distinct but interdependent roles each team member plays. The session concludes with a review of recent updates from the American College of Cardiology and their practical implications for STEMI management going forward.

Compare different stress testing modalities. Discuss optimal imaging for suspected cardiac amyloidosis.

A brief historical perspective of AF ablation will be described. The latest technological advancements will then be emphasized for the bulk of the presentation.

Join fellow women in cardiology for a dedicated lunch session built around connection, conversation, and community. Michele Friday, MD, FACC, FSCAI (Director of the Women's Heart Program at UK King's Daughters and Chair of Women in Cardiology for KY-ACC) and Tammy (Tamar) Polonsky, MD (Associate Professor of Medicine at the University of Chicago, with expertise in cardiovascular epidemiology, prevention, and women's heart disease) will share clinical insight and personal perspective on advancing women's cardiovascular health and women's presence in the field. Whether you're early in your career or a seasoned clinician, this session is your space to share experiences, build relationships that extend well beyond the meeting room, and help shape what matters most to the women of KY-ACC.

This keynote provides a concise, high-level walkthrough of the newly released 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia. Rather than a deep technical dive, the session orients attendees to what's new, what's changed from prior guidance, and what these updates mean for day-to-day clinical decision-making around lipid management and cardiovascular risk reduction.

Talk 1: PREVENTING mistakes with PREVENT: Understanding the New PREVENT risk score — Dr. Tammy Polonsky

Talk 2: What do I need to know about Lp(a): The in’s and out’s. Understand the role of Lp(a) in cardiovascular disease with an emphasis on epidemiology, biology, testing, and preventive measures. The talk will also cover emerging therapies and updates on trials. — Dr. Dinesh Karla

Talk 3: Title: Navigating Lipid Management During Childbearing — Dr. Laxmi Mehta

This session brings together three focused presentations spanning the breadth of structural heart disease. The session opens with a review of aortic valve disease and its management, followed by a discussion of structural issues spanning pediatric and adult congenital heart disease. The session concludes with an examination of transcatheter edge-to-edge repair and transcatheter valve replacement techniques for the mitral and tricuspid valves, highlighting the rapid evolution of minimally invasive options for structural heart disease.